Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,902
archived clinical trials in
Irritable Bowel Syndrome (IBS)

Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy
A Pharmacogenetic Case-Control Study of Severe Diarrhea and Life-Threatening Neutropenia in Patients Treated With Irinotecan, 5-Fluorouracil and Leucovorin
Status: Enrolling
Updated:  7/14/2015
FirstHealth Moore Regional Hospital
1033
mi
from
Pinehurst, NC
Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy
A Pharmacogenetic Case-Control Study of Severe Diarrhea and Life-Threatening Neutropenia in Patients Treated With Irinotecan, 5-Fluorouracil and Leucovorin
Status: Enrolling
Updated: 7/14/2015
FirstHealth Moore Regional Hospital
1033
mi
from
Pinehurst, NC
Click here to add this to my saved trials
Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy
A Pharmacogenetic Case-Control Study of Severe Diarrhea and Life-Threatening Neutropenia in Patients Treated With Irinotecan, 5-Fluorouracil and Leucovorin
Status: Enrolling
Updated:  7/14/2015
New Hanover Regional Medical Center
1134
mi
from
Wilmington, NC
Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy
A Pharmacogenetic Case-Control Study of Severe Diarrhea and Life-Threatening Neutropenia in Patients Treated With Irinotecan, 5-Fluorouracil and Leucovorin
Status: Enrolling
Updated: 7/14/2015
New Hanover Regional Medical Center
1134
mi
from
Wilmington, NC
Click here to add this to my saved trials
Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy
A Pharmacogenetic Case-Control Study of Severe Diarrhea and Life-Threatening Neutropenia in Patients Treated With Irinotecan, 5-Fluorouracil and Leucovorin
Status: Enrolling
Updated:  7/14/2015
CCOP - Southeast Cancer Control Consortium
971
mi
from
Winston-Salem, NC
Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy
A Pharmacogenetic Case-Control Study of Severe Diarrhea and Life-Threatening Neutropenia in Patients Treated With Irinotecan, 5-Fluorouracil and Leucovorin
Status: Enrolling
Updated: 7/14/2015
CCOP - Southeast Cancer Control Consortium
971
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy
A Pharmacogenetic Case-Control Study of Severe Diarrhea and Life-Threatening Neutropenia in Patients Treated With Irinotecan, 5-Fluorouracil and Leucovorin
Status: Enrolling
Updated:  7/14/2015
Comprehensive Cancer Center of Wake Forest University
979
mi
from
Winston-Salem, NC
Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy
A Pharmacogenetic Case-Control Study of Severe Diarrhea and Life-Threatening Neutropenia in Patients Treated With Irinotecan, 5-Fluorouracil and Leucovorin
Status: Enrolling
Updated: 7/14/2015
Comprehensive Cancer Center of Wake Forest University
979
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy
A Pharmacogenetic Case-Control Study of Severe Diarrhea and Life-Threatening Neutropenia in Patients Treated With Irinotecan, 5-Fluorouracil and Leucovorin
Status: Enrolling
Updated:  7/14/2015
Veterans Affairs Medical Center - Fargo
632
mi
from
Fargo, ND
Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy
A Pharmacogenetic Case-Control Study of Severe Diarrhea and Life-Threatening Neutropenia in Patients Treated With Irinotecan, 5-Fluorouracil and Leucovorin
Status: Enrolling
Updated: 7/14/2015
Veterans Affairs Medical Center - Fargo
632
mi
from
Fargo, ND
Click here to add this to my saved trials
Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy
A Pharmacogenetic Case-Control Study of Severe Diarrhea and Life-Threatening Neutropenia in Patients Treated With Irinotecan, 5-Fluorouracil and Leucovorin
Status: Enrolling
Updated:  7/14/2015
Arthur G. James Cancer Hospital - Ohio State University
810
mi
from
Columbus, OH
Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy
A Pharmacogenetic Case-Control Study of Severe Diarrhea and Life-Threatening Neutropenia in Patients Treated With Irinotecan, 5-Fluorouracil and Leucovorin
Status: Enrolling
Updated: 7/14/2015
Arthur G. James Cancer Hospital - Ohio State University
810
mi
from
Columbus, OH
Click here to add this to my saved trials
Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy
A Pharmacogenetic Case-Control Study of Severe Diarrhea and Life-Threatening Neutropenia in Patients Treated With Irinotecan, 5-Fluorouracil and Leucovorin
Status: Enrolling
Updated:  7/14/2015
CCOP - Geisinger Clinic and Medical Center
1151
mi
from
Danville, PA
Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy
A Pharmacogenetic Case-Control Study of Severe Diarrhea and Life-Threatening Neutropenia in Patients Treated With Irinotecan, 5-Fluorouracil and Leucovorin
Status: Enrolling
Updated: 7/14/2015
CCOP - Geisinger Clinic and Medical Center
1151
mi
from
Danville, PA
Click here to add this to my saved trials
Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy
A Pharmacogenetic Case-Control Study of Severe Diarrhea and Life-Threatening Neutropenia in Patients Treated With Irinotecan, 5-Fluorouracil and Leucovorin
Status: Enrolling
Updated:  7/14/2015
Western Pennsylvania Hospital
974
mi
from
Pittsburgh, PA
Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy
A Pharmacogenetic Case-Control Study of Severe Diarrhea and Life-Threatening Neutropenia in Patients Treated With Irinotecan, 5-Fluorouracil and Leucovorin
Status: Enrolling
Updated: 7/14/2015
Western Pennsylvania Hospital
974
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy
A Pharmacogenetic Case-Control Study of Severe Diarrhea and Life-Threatening Neutropenia in Patients Treated With Irinotecan, 5-Fluorouracil and Leucovorin
Status: Enrolling
Updated:  7/14/2015
Lifespan: The Miriam Hospital
1425
mi
from
Providence, RI
Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy
A Pharmacogenetic Case-Control Study of Severe Diarrhea and Life-Threatening Neutropenia in Patients Treated With Irinotecan, 5-Fluorouracil and Leucovorin
Status: Enrolling
Updated: 7/14/2015
Lifespan: The Miriam Hospital
1425
mi
from
Providence, RI
Click here to add this to my saved trials
Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy
A Pharmacogenetic Case-Control Study of Severe Diarrhea and Life-Threatening Neutropenia in Patients Treated With Irinotecan, 5-Fluorouracil and Leucovorin
Status: Enrolling
Updated:  7/14/2015
Veterans Affairs Medical Center - Dallas
353
mi
from
Dallas, TX
Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy
A Pharmacogenetic Case-Control Study of Severe Diarrhea and Life-Threatening Neutropenia in Patients Treated With Irinotecan, 5-Fluorouracil and Leucovorin
Status: Enrolling
Updated: 7/14/2015
Veterans Affairs Medical Center - Dallas
353
mi
from
Dallas, TX
Click here to add this to my saved trials
Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy
A Pharmacogenetic Case-Control Study of Severe Diarrhea and Life-Threatening Neutropenia in Patients Treated With Irinotecan, 5-Fluorouracil and Leucovorin
Status: Enrolling
Updated:  7/14/2015
Simmons Cancer Center at University of Texas Southwestern Medical Center - Dalas
344
mi
from
Dallas, TX
Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy
A Pharmacogenetic Case-Control Study of Severe Diarrhea and Life-Threatening Neutropenia in Patients Treated With Irinotecan, 5-Fluorouracil and Leucovorin
Status: Enrolling
Updated: 7/14/2015
Simmons Cancer Center at University of Texas Southwestern Medical Center - Dalas
344
mi
from
Dallas, TX
Click here to add this to my saved trials
Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy
A Pharmacogenetic Case-Control Study of Severe Diarrhea and Life-Threatening Neutropenia in Patients Treated With Irinotecan, 5-Fluorouracil and Leucovorin
Status: Enrolling
Updated:  7/14/2015
Green Mountain Oncology Group
1339
mi
from
Bennington, VT
Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy
A Pharmacogenetic Case-Control Study of Severe Diarrhea and Life-Threatening Neutropenia in Patients Treated With Irinotecan, 5-Fluorouracil and Leucovorin
Status: Enrolling
Updated: 7/14/2015
Green Mountain Oncology Group
1339
mi
from
Bennington, VT
Click here to add this to my saved trials
Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy
A Pharmacogenetic Case-Control Study of Severe Diarrhea and Life-Threatening Neutropenia in Patients Treated With Irinotecan, 5-Fluorouracil and Leucovorin
Status: Enrolling
Updated:  7/14/2015
Vermont Cancer Center at University of Vermont
1356
mi
from
Burlington, VT
Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy
A Pharmacogenetic Case-Control Study of Severe Diarrhea and Life-Threatening Neutropenia in Patients Treated With Irinotecan, 5-Fluorouracil and Leucovorin
Status: Enrolling
Updated: 7/14/2015
Vermont Cancer Center at University of Vermont
1356
mi
from
Burlington, VT
Click here to add this to my saved trials
Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy
A Pharmacogenetic Case-Control Study of Severe Diarrhea and Life-Threatening Neutropenia in Patients Treated With Irinotecan, 5-Fluorouracil and Leucovorin
Status: Enrolling
Updated:  7/14/2015
Veterans Affairs Medical Center - White River Junction
1390
mi
from
White River Junction, VT
Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy
A Pharmacogenetic Case-Control Study of Severe Diarrhea and Life-Threatening Neutropenia in Patients Treated With Irinotecan, 5-Fluorouracil and Leucovorin
Status: Enrolling
Updated: 7/14/2015
Veterans Affairs Medical Center - White River Junction
1390
mi
from
White River Junction, VT
Click here to add this to my saved trials
Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy
A Pharmacogenetic Case-Control Study of Severe Diarrhea and Life-Threatening Neutropenia in Patients Treated With Irinotecan, 5-Fluorouracil and Leucovorin
Status: Enrolling
Updated:  7/14/2015
Martha Jefferson Hospital
1053
mi
from
Charlottesville, VA
Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy
A Pharmacogenetic Case-Control Study of Severe Diarrhea and Life-Threatening Neutropenia in Patients Treated With Irinotecan, 5-Fluorouracil and Leucovorin
Status: Enrolling
Updated: 7/14/2015
Martha Jefferson Hospital
1053
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy
A Pharmacogenetic Case-Control Study of Severe Diarrhea and Life-Threatening Neutropenia in Patients Treated With Irinotecan, 5-Fluorouracil and Leucovorin
Status: Enrolling
Updated:  7/14/2015
Virginia Oncology Associates - Norfolk
1186
mi
from
Norfolk, VA
Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy
A Pharmacogenetic Case-Control Study of Severe Diarrhea and Life-Threatening Neutropenia in Patients Treated With Irinotecan, 5-Fluorouracil and Leucovorin
Status: Enrolling
Updated: 7/14/2015
Virginia Oncology Associates - Norfolk
1186
mi
from
Norfolk, VA
Click here to add this to my saved trials
Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy
A Pharmacogenetic Case-Control Study of Severe Diarrhea and Life-Threatening Neutropenia in Patients Treated With Irinotecan, 5-Fluorouracil and Leucovorin
Status: Enrolling
Updated:  7/14/2015
MBCCOP - Massey Cancer Center
1113
mi
from
Richmond, VA
Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy
A Pharmacogenetic Case-Control Study of Severe Diarrhea and Life-Threatening Neutropenia in Patients Treated With Irinotecan, 5-Fluorouracil and Leucovorin
Status: Enrolling
Updated: 7/14/2015
MBCCOP - Massey Cancer Center
1113
mi
from
Richmond, VA
Click here to add this to my saved trials
Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy
A Pharmacogenetic Case-Control Study of Severe Diarrhea and Life-Threatening Neutropenia in Patients Treated With Irinotecan, 5-Fluorouracil and Leucovorin
Status: Enrolling
Updated:  7/14/2015
Oncology and Hematology Associates of Southwest Virginia
979
mi
from
Roanoke, VA
Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy
A Pharmacogenetic Case-Control Study of Severe Diarrhea and Life-Threatening Neutropenia in Patients Treated With Irinotecan, 5-Fluorouracil and Leucovorin
Status: Enrolling
Updated: 7/14/2015
Oncology and Hematology Associates of Southwest Virginia
979
mi
from
Roanoke, VA
Click here to add this to my saved trials
Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy
A Pharmacogenetic Case-Control Study of Severe Diarrhea and Life-Threatening Neutropenia in Patients Treated With Irinotecan, 5-Fluorouracil and Leucovorin
Status: Enrolling
Updated:  7/14/2015
St Mary's Medical Center
840
mi
from
Huntington, WV
Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy
A Pharmacogenetic Case-Control Study of Severe Diarrhea and Life-Threatening Neutropenia in Patients Treated With Irinotecan, 5-Fluorouracil and Leucovorin
Status: Enrolling
Updated: 7/14/2015
St Mary's Medical Center
840
mi
from
Huntington, WV
Click here to add this to my saved trials
Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy
A Pharmacogenetic Case-Control Study of Severe Diarrhea and Life-Threatening Neutropenia in Patients Treated With Irinotecan, 5-Fluorouracil and Leucovorin
Status: Enrolling
Updated:  7/14/2015
CCOP - St. Vincent Hospital Cancer Center, Green Bay
689
mi
from
Green Bay, WI
Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy
A Pharmacogenetic Case-Control Study of Severe Diarrhea and Life-Threatening Neutropenia in Patients Treated With Irinotecan, 5-Fluorouracil and Leucovorin
Status: Enrolling
Updated: 7/14/2015
CCOP - St. Vincent Hospital Cancer Center, Green Bay
689
mi
from
Green Bay, WI
Click here to add this to my saved trials
Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy
A Pharmacogenetic Case-Control Study of Severe Diarrhea and Life-Threatening Neutropenia in Patients Treated With Irinotecan, 5-Fluorouracil and Leucovorin
Status: Enrolling
Updated:  7/14/2015
Ministry Medical Group - Northern Region
695
mi
from
Rhinelander, WI
Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy
A Pharmacogenetic Case-Control Study of Severe Diarrhea and Life-Threatening Neutropenia in Patients Treated With Irinotecan, 5-Fluorouracil and Leucovorin
Status: Enrolling
Updated: 7/14/2015
Ministry Medical Group - Northern Region
695
mi
from
Rhinelander, WI
Click here to add this to my saved trials
Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy
A Pharmacogenetic Case-Control Study of Severe Diarrhea and Life-Threatening Neutropenia in Patients Treated With Irinotecan, 5-Fluorouracil and Leucovorin
Status: Enrolling
Updated:  7/14/2015
McGill University
1355
mi
from
Montreal,
Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy
A Pharmacogenetic Case-Control Study of Severe Diarrhea and Life-Threatening Neutropenia in Patients Treated With Irinotecan, 5-Fluorouracil and Leucovorin
Status: Enrolling
Updated: 7/14/2015
McGill University
1355
mi
from
Montreal,
Click here to add this to my saved trials
Neomycin and Rifaximin Plus Neomycin in Treating Methane Positive Constipation Predominant Irritable Bowel Syndrome
Double-blind, Placebo Controlled Trial Comparing Neomycin to Rifaximin Plus Neomycin in the Treatment of Methane Positive Subjects With Constipation-predominant Irritable Bowel Syndrome
Status: Enrolling
Updated:  7/17/2015
Cedars-Sinai Medical Center
1168
mi
from
Los Angeles, CA
Neomycin and Rifaximin Plus Neomycin in Treating Methane Positive Constipation Predominant Irritable Bowel Syndrome
Double-blind, Placebo Controlled Trial Comparing Neomycin to Rifaximin Plus Neomycin in the Treatment of Methane Positive Subjects With Constipation-predominant Irritable Bowel Syndrome
Status: Enrolling
Updated: 7/17/2015
Cedars-Sinai Medical Center
1168
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Neomycin and Rifaximin Plus Neomycin in Treating Methane Positive Constipation Predominant Irritable Bowel Syndrome
Double-blind, Placebo Controlled Trial Comparing Neomycin to Rifaximin Plus Neomycin in the Treatment of Methane Positive Subjects With Constipation-predominant Irritable Bowel Syndrome
Status: Enrolling
Updated:  7/17/2015
Georgia Health Sciences University
932
mi
from
Augusta, GA
Neomycin and Rifaximin Plus Neomycin in Treating Methane Positive Constipation Predominant Irritable Bowel Syndrome
Double-blind, Placebo Controlled Trial Comparing Neomycin to Rifaximin Plus Neomycin in the Treatment of Methane Positive Subjects With Constipation-predominant Irritable Bowel Syndrome
Status: Enrolling
Updated: 7/17/2015
Georgia Health Sciences University
932
mi
from
Augusta, GA
Click here to add this to my saved trials
Use of SBI in IBS Subjects Following a Successful Treatment of Small Intestinal Bacterial Overgrowth
Use of Serum-derived Immunoglobulin/Protein Isolate (SBI) for the Maintenance of Health in Subjects With Irritable Bowel Syndrome (IBS) Following Successful Treatment of Small Intestinal Bacterial Overgrowth (SIBO)
Status: Enrolling
Updated:  7/27/2015
GI Motility Program Cedars-Sinai Medical Center
1175
mi
from
Los Angeles, CA
Use of SBI in IBS Subjects Following a Successful Treatment of Small Intestinal Bacterial Overgrowth
Use of Serum-derived Immunoglobulin/Protein Isolate (SBI) for the Maintenance of Health in Subjects With Irritable Bowel Syndrome (IBS) Following Successful Treatment of Small Intestinal Bacterial Overgrowth (SIBO)
Status: Enrolling
Updated: 7/27/2015
GI Motility Program Cedars-Sinai Medical Center
1175
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Prevalence of Cytomegalovirus, Epstein Barr Virus and Human Herpes 6 Virus in Inflammatory Bowel Disease
Prevalence of Cytomegalovirus, Epstein Barr Virus and Human Herpes 6 Virus DNA in Intestinal Mucosa of Patients With Inflammatory Bowel Disease
Status: Enrolling
Updated:  7/28/2015
Jackson Memorial Hospital
1319
mi
from
Miami, FL
Prevalence of Cytomegalovirus, Epstein Barr Virus and Human Herpes 6 Virus in Inflammatory Bowel Disease
Prevalence of Cytomegalovirus, Epstein Barr Virus and Human Herpes 6 Virus DNA in Intestinal Mucosa of Patients With Inflammatory Bowel Disease
Status: Enrolling
Updated: 7/28/2015
Jackson Memorial Hospital
1319
mi
from
Miami, FL
Click here to add this to my saved trials
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated:  7/31/2015
Mayo Clinic Scottsdale
835
mi
from
Scottsdale, AZ
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated: 7/31/2015
Mayo Clinic Scottsdale
835
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated:  7/31/2015
Aurora Presbyterian Hospital
401
mi
from
Aurora, CO
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated: 7/31/2015
Aurora Presbyterian Hospital
401
mi
from
Aurora, CO
Click here to add this to my saved trials
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated:  7/31/2015
Boulder Community Hospital
427
mi
from
Boulder, CO
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated: 7/31/2015
Boulder Community Hospital
427
mi
from
Boulder, CO
Click here to add this to my saved trials
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated:  7/31/2015
Penrose Cancer Center at Penrose Hospital
398
mi
from
Colorado Springs, CO
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated: 7/31/2015
Penrose Cancer Center at Penrose Hospital
398
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated:  7/31/2015
Porter Adventist Hospital
407
mi
from
Denver, CO
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated: 7/31/2015
Porter Adventist Hospital
407
mi
from
Denver, CO
Click here to add this to my saved trials
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated:  7/31/2015
Rose Medical Center
406
mi
from
Denver, CO
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated: 7/31/2015
Rose Medical Center
406
mi
from
Denver, CO
Click here to add this to my saved trials
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated:  7/31/2015
St. Anthony Central Hospital
411
mi
from
Denver, CO
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated: 7/31/2015
St. Anthony Central Hospital
411
mi
from
Denver, CO
Click here to add this to my saved trials
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated:  7/31/2015
Presbyterian - St. Luke's Medical Center
409
mi
from
Denver, CO
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated: 7/31/2015
Presbyterian - St. Luke's Medical Center
409
mi
from
Denver, CO
Click here to add this to my saved trials
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated:  7/31/2015
Swedish Medical Center
408
mi
from
Englewood, CO
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated: 7/31/2015
Swedish Medical Center
408
mi
from
Englewood, CO
Click here to add this to my saved trials
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated:  7/31/2015
North Colorado Medical Center
411
mi
from
Greeley, CO
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated: 7/31/2015
North Colorado Medical Center
411
mi
from
Greeley, CO
Click here to add this to my saved trials
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated:  7/31/2015
Sky Ridge Medical Center
401
mi
from
Lone Tree, CO
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated: 7/31/2015
Sky Ridge Medical Center
401
mi
from
Lone Tree, CO
Click here to add this to my saved trials
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated:  7/31/2015
Hope Cancer Care Center at Longmont United Hospital
425
mi
from
Longmont, CO
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated: 7/31/2015
Hope Cancer Care Center at Longmont United Hospital
425
mi
from
Longmont, CO
Click here to add this to my saved trials
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated:  7/31/2015
McKee Medical Center
433
mi
from
Loveland, CO
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated: 7/31/2015
McKee Medical Center
433
mi
from
Loveland, CO
Click here to add this to my saved trials
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated:  7/31/2015
North Suburban Medical Center
410
mi
from
Thornton, CO
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated: 7/31/2015
North Suburban Medical Center
410
mi
from
Thornton, CO
Click here to add this to my saved trials
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated:  7/31/2015
Exempla Lutheran Medical Center
416
mi
from
Wheat Ridge, CO
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated: 7/31/2015
Exempla Lutheran Medical Center
416
mi
from
Wheat Ridge, CO
Click here to add this to my saved trials
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated:  7/31/2015
Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center
1358
mi
from
Hartford, CT
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated: 7/31/2015
Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center
1358
mi
from
Hartford, CT
Click here to add this to my saved trials
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated:  7/31/2015
Tunnell Cancer Center at Beebe Medical Center
1229
mi
from
Lewes, DE
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated: 7/31/2015
Tunnell Cancer Center at Beebe Medical Center
1229
mi
from
Lewes, DE
Click here to add this to my saved trials
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated:  7/31/2015
CCOP - Christiana Care Health Services
1195
mi
from
Newark, DE
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated: 7/31/2015
CCOP - Christiana Care Health Services
1195
mi
from
Newark, DE
Click here to add this to my saved trials
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated:  7/31/2015
MBCCOP - Medical College of Georgia Cancer Center
932
mi
from
Augusta, GA
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated: 7/31/2015
MBCCOP - Medical College of Georgia Cancer Center
932
mi
from
Augusta, GA
Click here to add this to my saved trials
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated:  7/31/2015
Kapiolani Medical Center at Pali Momi
3719
mi
from
Aiea, HI
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated: 7/31/2015
Kapiolani Medical Center at Pali Momi
3719
mi
from
Aiea, HI
Click here to add this to my saved trials
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated:  7/31/2015
OnCare Hawaii, Incorporated - Lusitana
3717
mi
from
Honolulu, HI
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated: 7/31/2015
OnCare Hawaii, Incorporated - Lusitana
3717
mi
from
Honolulu, HI
Click here to add this to my saved trials
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated:  7/31/2015
Cancer Research Center of Hawaii
3717
mi
from
Honolulu, HI
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated: 7/31/2015
Cancer Research Center of Hawaii
3717
mi
from
Honolulu, HI
Click here to add this to my saved trials
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated:  7/31/2015
Kapiolani Medical Center for Women and Children
1307
mi
from
Honolulu, HI
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated: 7/31/2015
Kapiolani Medical Center for Women and Children
1307
mi
from
Honolulu, HI
Click here to add this to my saved trials
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated:  7/31/2015
Hawaii Medical Center - East
3717
mi
from
Honolulu, HI
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Phase III, Randomized, Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated: 7/31/2015
Hawaii Medical Center - East
3717
mi
from
Honolulu, HI
Click here to add this to my saved trials